Chickenpox immunisation disrupted by manufacturing issue at GSK

GlaxoSmithKline has stopped production of chickenpox vaccines, saying it will not restart shipping them until the second quarter, because of quality issues.

The disrupted production has already led to calls for rationing in Germany, a Reuters report said.

Two vaccines, both containing a chickenpox component, have been affected: Priorix-Tetra, a combined vaccine for measles, mumps, rubella and varicella, and Varilrix, a single chickenpox shot.

“We’re committed to resolve this supply disruption situation as soon as possible and are actively involved in keeping regulatory authorities and customers informed as we look to minimise the impact of this temporary supply disruption.”

GlaxoSmithKline spokesperson reported by Reuters.


Related news:

GSK blames chickenpox vaccine shortage on plant problems (FiercePharma Manufacturing).

Production snag forces worldwide hold on GSK chickenpox vaccines (Reuters).

Don't miss your daily pharmaphorum news.
SUBSCRIBE free here.